Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Colorcon
US Department of Justice
Express Scripts
Farmers Insurance
Baxter
Chubb
Queensland Health

Generated: May 21, 2018

DrugPatentWatch Database Preview

TRANXENE SD Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Tranxene Sd, and what generic alternatives are available?

Tranxene Sd is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in TRANXENE SD is clorazepate dipotassium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
Summary for TRANXENE SD
Drug patent expirations by year for TRANXENE SD
Pharmacology for TRANXENE SD
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for TRANXENE SD
Synonyms for TRANXENE SD
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compd. with potassium hydroxide (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compound with potassium hydroxide (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-,monopotassium salt, compd. with potassium hydroxide
27665-58-3
4306 CB
4306-CB
57109-90-7
AB 35616
Abbott-35616
AH 3232
Belseren
Bipotassium chlorazepate
C16H10ClN2O3.HKO.K
CB 4306
CHEBI:3762
CHEMBL2096631
Chlorazepam
Chlorazepate dipotassium
Clorazepate acid dipotassium salt
Clorazepate dipotassique
Clorazepate dipotassique [INN-French]
Clorazepate dipotassium
Clorazepate dipotassium (JP17/USP)
Clorazepate Dipotassium [USAN:JAN]
Clorazepate dipotassium [USAN:USP:JAN]
Clorazepato
Clorazepato [DCIT]
Clorazepato dipotasico
Clorazepato dipotasico [INN-Spanish]
D00694
DEA No. 2768
Dikalii clorazepas
Dikalii clorazepas [INN-Latin]
Dipotassium chlorazepate
Dipotassium clorazepate
Dipotassium clorazepate [INN]
EINECS 260-565-6
Gen-xene
LS-34023
Mendon
Modiur
Nevracten
Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate compound with potassium hydroxide (1:1)
Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate KOH
QCHSEDTUUKDTIG-UHFFFAOYSA-L
Softramal
Tencilan
TR 19119
Transilium
Tranxene
Tranxene (TN)
Tranxilen
Tranxilene
Tranxilium

US Patents and Regulatory Information for TRANXENE SD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for TRANXENE SD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-005 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-004 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Federal Trade Commission
Fish and Richardson
Moodys
Colorcon
Accenture
McKesson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.